Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bolinder

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Transplantation Proceedings|June 1, 1988
Pancreatic transplantation in diabetics with preuremic nephropathyG Tydén, C Brattström, J Bolinder, et al.
Transplantation Proceedings|October 1, 1987
Diagnosis of rejection in recipients of pancreatic grafts with enteric exocrine diversion by monitoring pancreatic juice cytology and amylase excretionG Tydén, F Reinholt, C Brattström, et al.
Diabetes, Obesity & Metabolism|June 2, 2012
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metforminÖ Ljunggren, J Bolinder, L Johansson, et al.
Lakartidningen|October 2, 1996
[The 1993 inventory in the county of Stockholm. Big differences when it comes to diabetic ambulatory care]J Ostman, J Bolinder, P M Jonsson, et al.
Diabetes, Obesity & Metabolism|August 3, 2013
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metforminJ Bolinder, Ö Ljunggren, L Johansson, et al.
Diabetologia|February 1, 2006
Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in SwedenI Waernbaum, G Blohmé, J Ostman, et al.
Journal of Internal Medicine|December 21, 2000
Direct medical costs for patients with type 2 diabetes in SwedenF Henriksson, C D Agardh, C Berne, et al.
Diabetologia|March 11, 2003
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS)H Borg, H J Arnqvist, E Björk, et al.
Diabetes|January 1, 1989
Long-term metabolic control in recipients of segmental-pancreas grafts with pancreaticoenterostomy or duct obstructionG Tydén, C Brattström, J Bolinder, et al.
Diabetologia|September 12, 2012
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialT Battelino, I Conget, B Olsen, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Transplantation Proceedings|June 1, 1988
Pancreatic transplantation in diabetics with preuremic nephropathyG Tydén, C Brattström, J Bolinder, et al.
Transplantation Proceedings|October 1, 1987
Diagnosis of rejection in recipients of pancreatic grafts with enteric exocrine diversion by monitoring pancreatic juice cytology and amylase excretionG Tydén, F Reinholt, C Brattström, et al.
Diabetes, Obesity & Metabolism|June 2, 2012
Dapagliflozin has no effect on markers of bone formation and resorption or bone mineral density in patients with inadequately controlled type 2 diabetes mellitus on metforminÖ Ljunggren, J Bolinder, L Johansson, et al.
Lakartidningen|October 2, 1996
[The 1993 inventory in the county of Stockholm. Big differences when it comes to diabetic ambulatory care]J Ostman, J Bolinder, P M Jonsson, et al.
Diabetes, Obesity & Metabolism|August 3, 2013
Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metforminJ Bolinder, Ö Ljunggren, L Johansson, et al.
Diabetologia|February 1, 2006
Excess mortality in incident cases of diabetes mellitus aged 15 to 34 years at diagnosis: a population-based study (DISS) in SwedenI Waernbaum, G Blohmé, J Ostman, et al.
Journal of Internal Medicine|December 21, 2000
Direct medical costs for patients with type 2 diabetes in SwedenF Henriksson, C D Agardh, C Berne, et al.
Diabetologia|March 11, 2003
Evaluation of the new ADA and WHO criteria for classification of diabetes mellitus in young adult people (15-34 yrs) in the Diabetes Incidence Study in Sweden (DISS)H Borg, H J Arnqvist, E Björk, et al.
Diabetes|January 1, 1989
Long-term metabolic control in recipients of segmental-pancreas grafts with pancreaticoenterostomy or duct obstructionG Tydén, C Brattström, J Bolinder, et al.
Diabetologia|September 12, 2012
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trialT Battelino, I Conget, B Olsen, et al.
Pageof 15